134.36
-1.06
(-0.78%)
At close: April 17 at 6:52:03 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 11 | 12 |
Avg. Estimate | 3.42B | 3.44B | 13.93B | 14.6B |
Low Estimate | 3.38B | 3.35B | 13.69B | 13.63B |
High Estimate | 3.48B | 3.53B | 14.21B | 15.31B |
Year Ago Sales | 3.12B | 3.23B | 12.82B | 13.93B |
Sales Growth (year/est) | 9.78% | 6.51% | 8.68% | 4.76% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0KU1.L | -- | -- | -- | -- |
S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/8/2025 |
Maintains | JMP Securities: Market Outperform to Market Outperform | 4/8/2025 |
Maintains | Goldman Sachs: Buy to Buy | 4/3/2025 |
Maintains | Citigroup: Neutral to Neutral | 4/2/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/4/2025 |
Maintains | B of A Securities: Buy to Buy | 1/30/2025 |